Therapeutic effects of a small molecule agonist of the relaxin receptor ML290 in liver fibrosisElena M. Kaftanovskaya, Alexander I. Agoulnik, Juan Marugán et al.|The FASEB Journal|2019Cited by 35
Targeting the relaxin/insulin-like family peptide receptor 1 and 2 with small molecule compoundsHooi Hooi Ng, Alexander I. Agoulnik, María Esteban-López|Molecular and Cellular Endocrinology|2018Cited by 8
Anti-apoptotic and Matrix Remodeling Actions of a Small Molecule Agonist of the Human Relaxin Receptor, ML290 in Mice With Unilateral Ureteral ObstructionHooi Hooi Ng, Alexander I. Agoulnik, Mariluz Soula et al.|Frontiers in Physiology|2021Cited by 2
Small molecule allosteric agonist of relaxin receptor ML290 demonstrates antifibrotic properties in liver fibrosisElena M. Kaftanovskaya, Alexander I. Agoulnik, Hooi Hooi Ng et al.|Endocrine Abstracts|2019Cited by 1
Therapeutic Effects of a Small Molecule Agonist of the Relaxin Receptor in Mice with Unilateral Ureteral ObstructionAlexander I. Agoulnik, Juan Marugán, Hooi Hooi Ng et al.|The FASEB Journal|2020Cited by 0